Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: A literature review comparing amlodipine and nifedipine GITS

Blood Pressure

Volumn 21, Issue SUPPL. 1, 2012, Pages 3-10

  Toal, Corey B ^a   Meredith, Peter A ^b   Elliott, Henry L ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Amlodipine; Blood pressure; Catecholamines; Extended release; GITS; Nifedipine; Norepinephrine; Sympathetic activation; Sympathetic nerve activity

Indexed keywords

AMLODIPINE; NIFEDIPINE; NORADRENALIN;

ADRENERGIC ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; DIASTOLIC BLOOD PRESSURE; FOURIER TRANSFORMATION; HEART MUSCLE TENSION; HEART RATE; HUMAN; HYPERTENSION; NORADRENALIN BLOOD LEVEL; PARASYMPATHETIC TONE; PERONEUS NERVE; POWER SPECTRUM; PRIORITY JOURNAL; SYMPATHETIC TONE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

AMLODIPINE; CALCIUM CHANNEL BLOCKERS; FEMALE; HUMANS; HYPERTENSION; MALE; NIFEDIPINE; SYMPATHETIC NERVOUS SYSTEM;

EID: 84864068025     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2012.690615     Document Type: Article

References (59)

1. Murphy MB, Scriven AJ, Brown MJ, Causon R, Dollery CT. The effects of nifedipine and hydralazine induced hypotension on sympathetic activity. Eur J Clin Pharmacol. 1982;23:479-482. (Pubitemid 13223422)
2. Curry SH, Lopez LM, Lambert CR, Kwon HR, Stack RK. Plasma concentrations and hemodynamic effects of intravenous, sublingual, and aerosolized nitroglycerin in patients undergoing cardiac catheterization. Biopharm Drug Dispos. 1993;14:107-118. (Pubitemid 23063341)
3. Lubsen J, Tijssen JGP, Kerkkamp HJJ. Early treatment of unstable angina in the coronary care unit: A randomized, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine of metoprolol or both. Br Heart J. 1986;56:400-413. (Pubitemid 17174609)
4. Behar S. Secondary prevention reinfarction Israeli nifedipine trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. Eur Heart J. 1988;9:354-364.
5. Grossman E., Messerli FH. Effect of calcium antagonists on plasma norepinephrine levels, heart rate, and blood pressure. Am J Cardiol. 1997;80:1453-1458. (Pubitemid 27523026)
6. Leenen FH, Holliwell DL. Antihypertensive effect of felodipine associated with persistent sympathetic activation and minimal regression of left ventricular hypertrophy. Am J Cardiol. 1992;69:639-645.
7. Leenen FHH, Myers MG, Joyner CD, Toal CB. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine- GITS versus felodipine-ER versus enalapril. Can J Cardiol. 2002;18:1285-1293. (Pubitemid 36215779)
8. de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nadeau R, Larochelle P. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients. J Hypertens. 1998; 16:1357-1369. (Pubitemid 28408419)
9. Pagani M, Lombardi F, Guzzeti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfato G, Dell Orto S, Piccaluga G. Power spectral analysis of heart rate and arterial pressure variables as a marker of sympatho-vagal interaction in man and dog. Circ Res. 1986;59:178-193. (Pubitemid 16017873)
10. Julius S. Sympathetic hyperactivity and coronary risk in hypertension. Hypertension. 1993;21:886-893. (Pubitemid 23166934)
11. Palatini P, Julius S. Heart rate and the cardiovascular risk. J Hypertens. 1997;15:3-17. (Pubitemid 27075981)
12. Kleinbloesem CH, van Brummelen P, van de Linde JA, Voogd PJ, Breimer DD.Nifedipine: Kinetics and dynamics in healthy subjects. Clin Pharmacol Ther. 1984;35:742-749. (Pubitemid 14077477)
13. Kleinbloesem CH, van Harten J, de Leede LGJ, van Brummelen P, Breimer DD. Nifedipine kinetics and dynamics during rectal infusion to steady state with an osmotic system. Clin Pharmacol Ther. 1984;36:396-401. (Pubitemid 14040292)
14. Myers M.G., Raemsch K. D. Comparative pharmacokinetics and antihypertensive effects of the nifedipine tablet and capsule. J Cardiovasc Pharmacol. 1987;10 Suppl 10:S76-S78.
15. Toal CB, Meredith PA, Elliott HL. Once Daily Nifedipine: The formulation dictates the pharmacokinetic characteristics and the therapeutic responses. Int J Clin Pharmacol. 2012;50:202-217.
16. Huang BS, Leenen FHH. Sympathoinhibitory and depressor effects of amlodipine in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 2003;42:153-160. (Pubitemid 36899665)
17. Murzenok PP, Huang BS, Leenen FHH. Sympathoinhibition by central and peripheral infusion of nifedipine in spontaneously hypertensive rats. Hypertension. 2000;35:631-636. (Pubitemid 30108160)
18. ALLHAT Officers and Coordinators. Major outcomes in high risk hypertensive patients randomized to angiotensin converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2002;288:2981-2997.
19. Brown MJ, Palmer CR, Castaigne A, de Leeuw PW, Mancia G, Rosenthal, T, Ruilope LM. Morbidity and mortality in patients randomised to double-blind treatment with a long acting calcium channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a goal in hypertension treatment (INSIGHT). Lancet. 2000;356:366-372. (Pubitemid 30487492)
20. Lopez LM, Thorman AD, Mehta JL. Effects of amlodipine on blood pressure, heart rate, catecholamines, lipids and responses to adrenergic stimulus. Am J Cardiol. 1990;66: 1269-1271.
21. Donati L, Buhler FR, Beretta-Piccoli C, Kusch F, Heinen G. Antihypertensive mechanism of amlodipine in essential hypertension: Role of pressor reactivity to norepinephrine and Angiotensin II. Clin Pharmacol Ther. 1992;52:50-59.
22. Leenen FHH, Fourney A. Comparison of the effects of amlodipine and diltiazem on 24-hour blood pressure, plasma catecholamines, and left ventricular mass. Am J Cardiol. 1996;78:203-207. (Pubitemid 26244370)
23. Sasaguri M, Matsumoto N, Noda K, Koga M, Kinoshita A, Ideishi M, Arakawa K. Amlodipine lowers blood pressure without increasing sympathetic activity or activating the renin - angiotensin system in patients with essential hypertension. Eur J Clin Pharmacol. 1997;53:197-201. (Pubitemid 28018291)
24. Hamada T, Watanabe M, Kaneda T, Ohtahara A, Kinugawa T, Hisatome I, Fujimoto Y, Yoshida A, Shigemasa C. Evaluation of changes in sympathetic nerve activity and heart rate in essential hypertensive patients induced by amlodipine and nifedipine. J Hypertens. 1998;16:111-118. (Pubitemid 28069827)
25. Sakata K, Shirotani M, Yoshida H, Nawada R, Obayashi K, Togi K, Miho N. Effects of Amlodipine and Cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension. Hypertension. 1999;33:1447-1452. (Pubitemid 29282669)
26. Malamani GD, Corradi L, Zoppi A Mugellini A, Preti P, Mennoia VN, Finardi G, Fogari R. Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension. J Hypertens. 1999;17 Suppl 3:S134.
27. Spence JD, Munoz C, Huff MW, Tokmakjian S. Effect of amlodipine on hemodynamic and endocrine responses to mental stress. Am J Hypertens. 2000;13:518-522. (Pubitemid 30330714)
28. Fogari R, Zoppi A, Corradi L, Preti P, Malamani GD, Mugellini A. Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension. J Hypertens. 2000;18:1871-1875.
29. Lefrandt JD, Heitmann J, Sevre K, Castellano M, Hausberg M, Fallon M, Urbigkeit A, Restrup M, Agabiti-Rosei E, Rahn KH, Murphy M, Zannad F, de Kam PJ, Smit AJ. Contrasting effects of verapamil and amlodipine on cardiovascular stress responses in hypertension. J Clin Pharmacol. 2001; 52:687-692. (Pubitemid 34015627)
30. Struck J, Muck P, Trubger D, Handrock R, Weidinger G, Dendorfer A, Dodt C. Effects of selective angiotensin II receptor blockade on sympathetic nerve activity in primary hypertensive subjects. J Hypertens. 2002;20:1143-1149. (Pubitemid 34913633)
31. Eguchi K, Kario K, Shimada K. Differential effects of a longacting angiotensin converting enzyme inhibitor (temocapril) and a long-acting calcium antagonist (amlodipine) on ventricular ectopic beats in older hypertensive patients. Hypertens Res. 2002;25:329-333. (Pubitemid 34752550)
32. Binggeli C, Corti R, Sudano I, Luscher TF, Noll G. Effects of chronic calcium channel blockade on sympathetic nerve activity in hypertension. Hypertension. 2002;39:892-896. (Pubitemid 34437545)
33. Ohbayashi Y, Tsutamoto T, Sakaguchi T, Tanaka T, Kanamori T, Yokohama H, et al. Effect of an angiotensin II Type 1 receptor blocker, Valsartan, on neurohumoral factors in patients with hypertension: Comparison with a long-acting calcium channel antagonist, amlodipine. J Cardiovasc Pharmacol. 2003;42 Suppl 1:S71-S74. (Pubitemid 37467080)
34. Malacco E, Piazza S, Scandiani L, Zoppi A. Effects of valsartan/ hydrochlorothiazide and amlodipine on ambulatory blood pressure and plasma norepinephrine levels in high-risk hypertensive patients. Adv Ther. 2004;21:149-161. (Pubitemid 39350473)
35. Karas M, Lacourciere Y, LeBlanc AR, Nadeau R, Dube B, Florescu M, et al. Effect of the renin - angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients. J Hypertens. 2005;23:1251-1260. (Pubitemid 40862730)
36. Leenen FHH, Coletta E, White R. Sympatho-excitatory responses to once-daily dihydropyridines in young versus older hypertensive patients: amlodipine versus felodipine extended release. J Hypertens. 2006;24:177-184. (Pubitemid 41818103)
37. Ruzicka M, Coletta E, Leenen FHH. Does blockade of the renin angiotensin system affect sympathetic and blood pressure responses to amlodipine in young hypertensive patients? Am J Hypertens. 2007;20:1202-1208. (Pubitemid 47588821)
38. de Champlain J, Karas M, Assouline L, Nadeau R, LeBlanc R, Dube B, et al. Effects of valsartan or amlodipine alone or in combination on plasma catecholamine levels at rest and during standing in hypertensive patients. J Clin Hypertens. 2007;9:168-178.
39. Larochelle P, Karas M, Lamarre-Cliché M, Lacourciere Y, de Champlain. Effect of 8 weeks administration of antihypertensive agent on plasma catecholamines, renin and aldosterone in patients with essential hypertension. J Hypertens. 2008;26 Suppl 1:S462.
40. Sanjuliani AF, Genelhu-Fagunde V, Barroso SG, Duarte AVB, Rodrigues MLG, Castro RSP, et al. Effect of a imidazoline agonist on sympathetic activity and components of the insulin resistance syndrome in obese hypertensive Brazilian patients. J Hypertens. 2002;20 Suppl 4:S206.
41. Frohlich ED, McLoughlin MJ, Losem CJ, Ketelhut R, Messerli FH. Hemodynamic comparison of two nifedipine formulations in patients with essential hypertension. Am J Cardiol. 1991;66:1346-1350.
42. Philips RA, Ardeljan M, Shimabukuro S, Goldman ME, Garbowit DL, Eison HB, Krakoff LR. Effects of nifedipine-GITS on left ventricular mass and left ventricular fi lling. J Cardiovasc Pharmacol. 1992;19 Suppl 2:S28-S34.
43. Halperin AK, Icenogle MV, Kapsner CO, Chick TW, Roehnert J, Murata GH. A comparison of the effects of nifedipine and verapamil on exercise performance in patients with mild to moderate hypertension. Am J Hypertens. 1993;6:1025-1032. (Pubitemid 24037574)
44. DeQuattro V, Lee D. Equivalent reduction of proteinuria in hypertensives by either nifedipine GITS or enalapril: Disparate effects on neurohormones and ambulatory blood pressure and the infl uence of salt. Cardiology. 1997;88 Suppl 3:38-42.
45. James MA, Rakicka H, Panerai RB, Potter JF. Barorefl ex sensitivity changes with calcium antagonist therapy in elderly subjects with isolated systolic hypertension. J Human Hypertens. 1999;13:87-95. (Pubitemid 29101290)
46. Pellizzer A, Kamen PW, Esler MD, Lim S, Krum H. Comparative effects of mibefradil and nifedipine gastrointestinal therapeutic system on autonomic function in patients with mild to moderate essential hypertension. J Hypertens. 2001;19:279-285. (Pubitemid 32116279)
47. Diamond JA, Krakoff LR, Goldman A, Coplan N, Gharavi A, Martin K, et al. Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension. Am J Hypertens. 2001;14: 231-240. (Pubitemid 32202706)
48. Fogari R, Mugellini A, Zoppi A, Corradi L, Rinaldi A, Derosa G, et al. Differential effects of lercanidipine and nifedipine GITS on plasma norepinephrine in chronic treatment of hypertension. Am J Hypertens. 2003;16:596-599. (Pubitemid 36829711)
49. Ruzicka M, Coletta E, Floras J, Leenen FHH. Effects of low-dose nifedipine GITS on sympathetic activity in young and older patients with hypertension. J Hypertens. 2004;22: 1039-1044. (Pubitemid 38680481)
50. Fogari R, Preti P, Zoppi A, Corradi L, Pasotti C, Rinaldi A, et al. Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation. Am J Hypertens. 2005;18:577-583. (Pubitemid 40692422)
51. Brown MJ, Toal CB. Formulation of long-acting nifedipine tablets infl uences the heart rate and sympathetic nervous system response in hypertensive patients. Br J Clin Pharmacol. 2007;65:646-652. (Pubitemid 351535083)
52. Calhoun DA. Effects of 4 weeks of amlodipine therapy on muscle sympathetic nerve activity. Journal of Investigative Medicine. 1997;70A.
53. Dodt C, Struck J, Muck P, Trubger D, Handrock R, Weidinger G, et al. Different effects of valsartan and amlodipine on muscle sympathetic activity in hypertensive subjects. J. Hypertens. 2000;18 Suppl 4:S29.
54. Minami J, Ishimitsu T, Kawano Y, Matsuoka H. Effects of amlodipine and nifedipine retard on autonomic nerve activity in hypertensive patients. Clin Exp Pharmacol Physiol. 1998; 25:572-576. (Pubitemid 28321624)
55. Lucini D, Strappazzon P, Milani RV, Messerli FH, Pagani M. Improved baroreflex control in hypertensive patients treated with amlodipine. J Hypertens. 1999;17 Suppl 3:S253.
56. Siche JP, Baguet JP, Fagret D, Tremel F, de Gaudemaris R, Mallion J. Effects of amlodipine on baroreflex and sympathetic nervous system activity in mild-to-moderate hypertension. Am J Hypertens. 2001;14:424-428. (Pubitemid 32417597)
57. Sahin I, Kosat F, Altunkan S, Gunaydin M. Comparison of the effects of amlodipine and verapamil on autonomic activity in hypertensive patients. Eur J Internal Med. 2004;15: 225-230. (Pubitemid 39024395)
58. Bilge AK, Atilgan D, Tukek T, Ozcan M, Ozben B, Koylan N, Meric M. Effects of amlodipine and fosinopril on heart rate variability and left ventricular mass in mild-to-moderate essential hypertension. Int J Clin Pract. 2005;59:306-310. (Pubitemid 40352747)
59. Lindqvist M, Kahan T, Melcher A, Ekholm M, Hjemdahl P. Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity. J Hypertens. 2007;25:169-175. (Pubitemid 44885679)